Contrasting BG Medicine (OTCMKTS:BGMD) & Ardent Health (NYSE:ARDT)

Ardent Health (NYSE:ARDT) and BG Medicine (OTCMKTS:BGMD) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Ardent Health and BG Medicine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ardent Health	3.24%	19.02%	6.04%
BG Medicine	N/A	N/A	N/A

Risk & Volatility

Ardent Health has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, BG Medicine has a beta of 2.23, meaning that its share price is 123% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Ardent Health and BG Medicine, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2	4	6	0	2.33
BG Medicine	0	0	0	0	0.00

Ardent Health currently has a consensus target price of $14.67, indicating a potential upside of 58.88%. Given Ardent Health’s stronger consensus rating and higher probable upside, research analysts plainly believe Ardent Health is more favorable than BG Medicine.

Earnings and Valuation

This table compares Ardent Health and BG Medicine”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$5.97 billion	0.22	$210.34 million	$1.45	6.37
BG Medicine	N/A	N/A	N/A	N/A	N/A

Ardent Health has higher revenue and earnings than BG Medicine.

Summary

Ardent Health beats BG Medicine on 7 of the 8 factors compared between the two stocks.

About Ardent Health

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

About BG Medicine

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.